Low creatinine clearance, glucocorticoid treatment, rheumatoid arthritis--different etiologies for low D-hormone syndrome and its associated increased risk for falls

J Rheumatol Suppl. 2005 Sep:76:44-6.

Abstract

Low D-hormone syndrome, a disorder related to low creatinine clearance (CrCl), is associated with a roughly 4-fold increase in risk for falls. Known conditions leading to low D-hormone syndrome are CrCl < 65 ml/min, drug interactions, and chronic inflammatory diseases. This article reviews recent studies showing that treatment with D-hormone analogs, such as alfacalcidol, can reduce the frequency of falls in patients with low D-hormone syndrome.

Publication types

  • Review

MeSH terms

  • Accidental Falls / prevention & control*
  • Age Factors
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy
  • Bone Density Conservation Agents / therapeutic use
  • Bone Diseases, Metabolic / blood
  • Bone Diseases, Metabolic / etiology*
  • Bone Diseases, Metabolic / metabolism
  • Calcitriol / blood
  • Calcitriol / deficiency*
  • Clinical Trials as Topic
  • Creatinine / metabolism*
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Hydroxycholecalciferols / therapeutic use
  • Kidney / enzymology
  • Kidney / metabolism*
  • Risk Factors
  • Steroid Hydroxylases / metabolism
  • Syndrome
  • Vitamins / therapeutic use

Substances

  • Bone Density Conservation Agents
  • Glucocorticoids
  • Hydroxycholecalciferols
  • Vitamins
  • Creatinine
  • Steroid Hydroxylases
  • vitamin D 1-alpha hydroxylase
  • Calcitriol
  • alfacalcidol